Equity Overview
Price & Market Data
Price: $2.16
Daily Change: -$0.01 / 0.46%
Range: $2.08 - $2.17
Market Cap: $218,037,152
Volume: 362,151
Performance Metrics
1 Week: -1.59%
1 Month: -14.76%
3 Months: 9.34%
6 Months: -65.63%
1 Year: -52.93%
YTD: -31.05%
Company Details
Employees: 83
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Acelyrin, Inc., a clinical biopharma company, focuses on identifying, acquiring, and accelerating the development and commercialization of transformative medicines. The company's lead product candidate is lonigutamab, a subcutaneously delivered monoclonal antibody targeting IGF-1R, which has completed Phase 2 clinical trial for the treatment of Thyroid Eye Disease (TED). Acelyrin, Inc. was incorporated in 2020 and is headquartered in Agoura Hills, California.